Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272


Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data.

Dmitrieva O, de Lusignan S, Macdougall IC, Gallagher H, Tomson C, Harris K, Desombre T, Goldsmith D.

BMC Nephrol. 2013 Jan 25;14:24. doi: 10.1186/1471-2369-14-24.


Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics.

Minutolo R, Locatelli F, Gallieni M, Bonofiglio R, Fuiano G, Oldrizzi L, Conte G, De Nicola L, Mangione F, Esposito P, Dal Canton A; REport of COmorbidities in non-Dialysis Renal Disease Population in Italy (RECORD-IT) Study Group.

Nephrol Dial Transplant. 2013 Dec;28(12):3035-45. doi: 10.1093/ndt/gft338. Epub 2013 Oct 21.


Over-representation of diabetic patients with renal anaemia in the primary care setting.

Mostafa S, Tagboto S, Robinson M, Burden A, Davies S.

Fam Pract. 2009 Jun;26(3):180-2. doi: 10.1093/fampra/cmp009. Epub 2009 Mar 2.


The effect of a multidisciplinary care clinic on the outcomes in pediatric chronic kidney disease.

Ajarmeh S, Er L, Brin G, Djurdjev O, Dionne JM.

Pediatr Nephrol. 2012 Oct;27(10):1921-7. doi: 10.1007/s00467-012-2209-6. Epub 2012 Jun 5.


The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study.

New JP, Aung T, Baker PG, Yongsheng G, Pylypczuk R, Houghton J, Rudenski A, New RP, Hegarty J, Gibson JM, O'Donoghue DJ, Buchan IE.

Diabet Med. 2008 May;25(5):564-9. doi: 10.1111/j.1464-5491.2008.02424.x.


An economic evaluation of intravenous versus oral iron supplementation in people on haemodialysis.

Wong G, Howard K, Hodson E, Irving M, Craig JC.

Nephrol Dial Transplant. 2013 Feb;28(2):413-20. doi: 10.1093/ndt/gfs487. Epub 2012 Nov 25.


Anaemia and its response to treatment with recombinant human erythropoietin in chronic kidney disease patients.

Abdu A, Arogundade F, Adamu B, Dutse AI, Sanusi A, Sani MU, Mijinyawa MS, Akinsola A, Borodo MM.

West Afr J Med. 2009 Sep-Oct;28(5):295-9.


2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.


Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland.

Mathieu CM, Teta D, Lötscher N, Golshayan D, Gabutti L, Kiss D, Martin PY, Burnier M.

BMC Nephrol. 2008 Dec 11;9:16. doi: 10.1186/1471-2369-9-16.


High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).

Verbeke N, Beguin Y, Wildiers H, Canon JL, Bries G, Bosly A, Van Belle S.

Support Care Cancer. 2012 Jan;20(1):23-8. doi: 10.1007/s00520-010-1045-0. Epub 2010 Nov 25.


Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.

Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P.

Am J Kidney Dis. 2013 Feb;61(2):238-46. doi: 10.1053/j.ajkd.2012.08.043. Epub 2012 Nov 16.


Prevalence of anaemia and its clinical management in patients with stages 3-5 chronic kidney disease not on dialysis in Catalonia: MICENAS I study.

Cases-Amenós A, Martínez-Castelao A, Fort-Ros J, Bonal-Bastons J, Ruiz MP, Vallés-Prats M, Coll-Piera E, Galcerán-Gui JM; Investigadores del Estudio Micenas I.

Nefrologia. 2014;34(2):189-98. doi: 10.3265/Nefrologia.pre2013.Dec.12261. English, Spanish.


Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS.

Akizawa T, Pisoni RL, Akiba T, Saito A, Fukuhara S, Asano Y, Hasegawa T, Port FK, Kurokawa K.

Nephrol Dial Transplant. 2008 Nov;23(11):3643-53. doi: 10.1093/ndt/gfn346. Epub 2008 Jun 24.


Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines.

Hung SC, Kuo KL, Tarng DC, Hsu CC, Wu MS, Huang TP.

Nephrology (Carlton). 2014 Dec;19(12):735-9. doi: 10.1111/nep.12332. Review.


EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.


Detection & management of anaemia in pregnancy in an urban primary health care institution.

Sharma A, Patnaik R, Garg S; Prema Ramachandran.

Indian J Med Res. 2008 Jul;128(1):45-51.


Prevalence and treatment of anemia with once-weekly epoetin alfa in patients with diabetes and chronic kidney disease.

Lorber DL, Provenzano R, McClellan W.

Endocr Pract. 2006 Sep-Oct;12(5):506-13.


The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease.

Portolés J, Gorriz JL, Rubio E, de Alvaro F, García F, Alvarez-Chivas V, Aranda P, Martinez-Castelao A; NADIR-3 Study Group.

BMC Nephrol. 2013 Jan 7;14:2. doi: 10.1186/1471-2369-14-2.


Prevalence of anaemia in pregnant women during the last trimester.

Msolla MJ, Kinabo JL.

Int J Food Sci Nutr. 1997 Jul;48(4):265-70.

Items per page

Supplemental Content

Write to the Help Desk